In this week’s video, Dr. Brian G.M. Durie discusses current treatments, including immune therapies, used to target and eliminate myeloma cells.

Genetic mutations create “parameters” that anti-myeloma therapies can target.

Have a question? Submit it to

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at

Previous Post
Is there a link between MGUS and kidney damage in myeloma patients?
Next Post
Cures Reported for Two Blood Diseases in One Week: Can Either One Be Applied to Myeloma?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.